However, due to intertwined effects of TREX1 on both the tumor and the immune system [43–45, 115, 116], the role of its variants in cancer may be complex, as some germline TREX1 variants have been associated with hematological malignancies in patients with autoimmune diseases [46]. Here, TREX1 is linked to hematologic disorder.